1. Department of Ophthalmology, Shandong Provincial Hospital Affiliated with Shandong University, Jinan 250021, China; 2. Department of Ophthalmology, Jinan Central Hospital Affiliated with Shandong University, Jinan 250013, China; 3. Department of Ophthalmology, the Second People′s Hospital of Liaocheng, Liaocheng 252600, China; 4. Department of Ophthalmology, Zibo Central Hospital, Zibo 255000, China
Objective To evaluate the safety and efficacy of epithelium-off corneal collagen cross-linking (CXL) induced by riboflavin and ultraviolet A light for keratoconus in teenagers. Methods The medical records of consecutive patients (30 eyes of 19 cases) at the age of 14-18 years treated with epithelium-off CXL for keratoconus were analyzed in this retrospective self-control study. Data from preperative and 3-, 6-, and 12-month postoperative examinations were analyzed by one way repeated ANOVA. The clinical evaluations included uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), maximum keratometry (Kmax), thinnest corneal thickness (TCT), and endothelial cell density (ECD). Results UCVA measured as the log of the minimum angle of resolution (LogMAR) was 0.78±0.33 at baseline before surgery and 0.77±0.34, 0.72±0.33, and 0.67±0.31 at 3-, 6-, and 12-months after surgery. There was significant improvement of UCVA at 12 months compared to the baseline (P＜0.001). LogMAR BCVA increased from 0.42±0.33 to 0.29±0.23 and 0.23±0.20 at 6- and 12-months after surgery (both P＜0.05). The Kmax value was 62.1±11.3 diopter (D) before treatment and improved significantlyto 60.4±9.9 D and 59.9±9.5 D at 6 and 12 months after treatment respectively. The preoperative TCT was 446±41 μm and thinned to 430±39 μm at 12 months after surgery (P＜0.001). There were no significant differences between the preoperative and 12-month postoperative ECD. No complications occurred in the overall group throughout the study period. Conclusion Epithelium-off CXL is safe and effective in treating teenage keratoconus. The procedure improved the visual acuity and keratometry values at 12 months after surgery.
Reeves SW, Stinnett S, Adelman RA, et al. Risk factors for progression to penetrating keratoplasty in patients with keratoconus[J]. Am J Ophthalmol, 2005, 140(4): 607-611. DOI: 10.1016/j.ajo.2005.05.029.
[3]
Wollensak G, Spoerl E, Seiler Z． Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus[J]. Am J Ophthalmol, 2003, 135(5): 620-627． DOI: 10.1016/S0002-9394(02)02220-1.
[4]
Hashemi H, Seyedian MA, Miraftab M, et al. Corneal collagen cross-linking with riboflavin and ultraviolet A irradiation for keratoconus: long-term results[J]. Ophthalmology, 2013, 120(8): 1515-1520. DOI: 10.1016/j.ophtha.2013.01.012.
[5]
Raiskup F, Theuring A, Pillunat LE, et al. Corneal collagen crosslinking with riboflavin and ultraviolet-A light in progressive keratoconus: Ten-year results[J]. J Cataract Refract Surg, 2015, 41(1): 41-46. DOI: 10.1016/j.jcrs.2014.09.033.
AlSuhaibani AH, Al-Rajhi AA, Al-Motowa S, et al. Inverse relationship between age and severity and sequelae of acute corneal hydrops associated with keratoconus[J]. Br J Ophthalmol, 2007(91): 984-985. DOI: 10.1136/bjo.2005.085878.
[8]
Kamiya K, Shimizu K, Ohmoto F. Effect of aging on corneal biomechanical parameters using the ocular response analyzer[J]. J Refract Surg, 2009, 25(10): 888-893. DOI: 10.3928/1081597X- 20090917-10.
[9]
McAnena L, O′Keefe M. Corneal collagen crosslinking in children with keratoconus[J]. J AAPOS, 2015, 19(3): 228-232. DOI: 10.1016/j.jaapos.2015.02.010.
[10]
Caporossi A, Mazzotta C, Baiocchi S, et al. Riboflavin-UVA- induced corneal collagen cross-linking in pediatric patients[J]. Cornea, 2012, 31(3): 227-231. DOI: 10.1097/ico.0b013e31822159f6.
[11]
Vinciguerra P, Albé E, Frueh BE, et al. Two-year corneal cross-linking results in patients younger than 18 years with documented progressive keratoconus[J]. Am J Ophthalmol, 2012, 154(3): 520-526. DOI: 10.1016/j.ajo.2012.03.020.
[12]
Arora R, Gupta D, Goyal JL, et al. Results of corneal collagen cross-linking in pediatric patients[J]. J Refract Surg, 2012, 28(11): 759-762. DOI: 10.3928/1081597X-20121011-02.
[13]
Soeters N, van der Valk R, Tahzib NG. Corneal crosslinking for treatment of progressive keratoconus in various agegroups[J]. J Refract Surg, 2014, 30(7): 454-460. DOI: 10.3928/1081597X- 20140527-03.
[14]
Kumar Kodavoor S, Arsiwala AZ, Ramamurthy D. One-year clinical study on efficacy of corneal cross-linking in Indian children with progressive keratoconus[J]. Cornea, 2014, 33(9): 919-922. DOI: 10.1097/ICO.0000000000000197.
[15]
Godefrooij Daniel A, Soeters N, Imhof Saskia M, et al. Corneal cross-linking for pediatric keratoconus: long-term results[J]. Cornea, 2016, 35(7): 954-958. DOI: 10.1097/ICO.0000000000000 819.
[16]
Toprak I, Yaylali V, Yildirim C. Visual, Topographic, and pachymetric effects of pediatric corneal collagen cross-linking[J]. J Pediatr Ophthalmol Strabismus, 2017, 54(2): 84-89. DOI: 10.3928/01913913-20160831-01.
[17]
Akhtar S, Almubrad T, Paladini I, et al. Keratoconus corneal architecture after riboflavin/ultraviolet A cross-linking: ultrastructural studies[J]. Mol Vis, 2013, 19(19): 1526-1537.
[18]
Balasubramanian Sivaraman A, Pye David C, Willcox Mark D. Effects of eye rubbing on the levels of protease, protease activity and cytokines in tears: relevance in keratoconus[J]. Clin Exp Optom, 2013, 96(2): 214-218. DOI: 10.1111/cxo.12038.
[19]
Greenstein SA, Fry KL, Hersh PS. Effect of topographic cone location on outcomes of corneal collagen cross-linking for keratoconus and corneal ectasia[J]. J Refract Surg, 2012, 28(6):397-405. DOI: 10.3928/1081597X-20120518-02.
[20]
Peyman A, Kamali A, Khushabi M, et al. Collagen cross-linking effect on progressive keratoconus in patients younger than 18 years of age: A clinical trial[J]. Adv Biomed Res, 2015, 23(4): 245. DOI: 10.4103/2277-9175.170240.
[21]
Uçakhanöö, Bayraktutar BN, Saglik A, et al. Pediatric corneal collagen cross-linking: long-term follow-up of visual, refractive, and topographic outcomes[J]. Cornea, 2016, 35(2): 162-168. DOI: 10.1097/ICO.0000000000000702.
Greenstein SA, Shah VP, Fry KL, et al. Corneal thickness changes after corneal collagen crosslinking for keratoconus and corneal ectasia: One-year results[J]. J Cataract Refract Surg, 2011, 37(4): 691-700. DOI: 10.1016/j.jcrs.2010.10.052.
[24]
Magli A, Forte R, Tortori A, et al. Epithelium-off corneal collagen cross-linking versus transepithelial cross-linking for pediatric keratoconus[J]. Cornea, 2013, 32(5): 597-601. DOI: 10. 1097/ICO.0b013e31826cf32d.
[25]
Salman AG. Transepithelial corneal collagen crosslinking for progressive keratoconus in a pediatric age group[J]. J Cataract Refract Surg, 2013, 39(8): 1164-1170. DOI: 10.1016/j.jcrs.2013.03. 017.
[26]
Buzzonetti L, Petrocelli G. Transepithelial corneal cross-linking in pediatric patients: early results[J]. J Refract Surg, 2012, 28(11): 763-767. DOI: 10.3928/1081597X-20121011-03.
[27]
Shetty R, Nagaraja H, Jayadev C, et al. Accelerated corneal collagen cross-linking in pediatric patients: two-year follow-up results[J]. Biomed Res Int, 2014, 2014: 894095. DOI: 10.1155/ 2014/894095.
[28]
Chatzis N, Hafezi F. Progression of keratoconus and efficacy of pediatric corneal collagen cross-linking in children and adolescents[J]. J Refract Surg, 2012, 28(11): 753-758. DOI: 10. 3928/1081597X-20121011-01.
[29]
Sandvik GF, Thorsrud A, Råen M, et al. Does corneal collagen crosslinking reduce the need for keratoplasties in patients with keratoconus?[J]. Cornea, 2015, 34(9): 991-995. DOI: 10.1097/ICO. 0000000000000460.
浙公网安备 33030202001892号